Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNS NASDAQ:BBNX NASDAQ:EMBC NASDAQ:KRMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$11.53-2.8%$12.39$11.48▼$25.36$548.45M1.12388,740 shs645,731 shsBBNXBeta Bionics$12.53-2.3%$15.68$8.89▼$24.50$556.26MN/A435,558 shs312,962 shsEMBCEmbecta$9.58-7.6%$10.62$9.20▼$21.48$606.05M1.08502,807 shs589,242 shsKRMDKORU Medical Systems$2.94-8.7%$3.20$1.86▼$5.05$148.57M0.52145,517 shs210,605 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-2.73%-6.49%-4.79%-4.39%-44.83%BBNXBeta Bionics-2.34%-6.14%-34.36%+14.53%+1,252,999,900.00%EMBCEmbecta-7.62%-8.15%+0.21%-15.52%-25.39%KRMDKORU Medical Systems-8.70%-22.63%-8.98%+28.38%+17.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAvanos Medical2.8803 of 5 stars0.05.00.00.01.91.72.5BBNXBeta BionicsN/AN/AN/AN/AN/AN/AN/AN/AEMBCEmbecta4.7532 of 5 stars3.23.03.30.02.93.33.8KRMDKORU Medical Systems2.7226 of 5 stars3.52.00.00.02.72.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 0.00N/AN/AN/ABBNXBeta Bionics 2.75Moderate Buy$23.4487.11% UpsideEMBCEmbecta 2.33Hold$19.33101.81% UpsideKRMDKORU Medical Systems 3.00Buy$4.5053.06% UpsideCurrent Analyst Ratings BreakdownLatest KRMD, EMBC, BBNX, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025BBNXBeta BionicsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$26.006/12/2025BBNXBeta BionicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$30.005/30/2025BBNXBeta BionicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$16.005/30/2025BBNXBeta BionicsWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$20.005/23/2025EMBCEmbectaBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$25.005/23/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.005/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.50(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$687.80M0.78$11.53 per share1.00$18.03 per share0.64BBNXBeta Bionics$65.12M8.34N/AN/A($5.72) per share-2.19EMBCEmbecta$1.12B0.50$3.08 per share3.11($12.80) per share-0.75KRMDKORU Medical Systems$33.65M4.03N/AN/A$0.37 per share7.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$392.10M-$8.37N/A6.66N/A-55.80%6.26%4.63%7/30/2025 (Estimated)BBNXBeta Bionics-$54.76MN/A0.00∞N/AN/AN/AN/AN/AEMBCEmbecta$78.30M$0.9010.643.120.674.89%-19.67%12.27%8/8/2025 (Estimated)KRMDKORU Medical Systems-$6.07M-$0.11N/AN/AN/A-15.09%-30.43%-19.41%8/6/2025 (Estimated)Latest KRMD, EMBC, BBNX, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q3 2025EMBCEmbecta$0.7720N/AN/AN/A$278.15 millionN/A8/6/2025Q2 2025KRMDKORU Medical Systems-$0.03N/AN/AN/A$9.46 millionN/A7/30/2025Q2 2025AVNSAvanos Medical$0.18N/AN/AN/A$165.50 millionN/A5/9/2025Q2 2025EMBCEmbecta$0.66$0.70+$0.04$0.40$261.77 million$259.00 million5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million5/6/2025Q1 2025AVNSAvanos Medical$0.19$0.26+$0.07$0.14$161.75 million$167.50 million5/6/2025Q1 2025BBNXBeta Bionics-$0.51-$0.52-$0.01-$0.93N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/ABBNXBeta BionicsN/AN/AN/AN/AN/AEMBCEmbecta$0.606.26%N/A66.67%N/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ALatest KRMD, EMBC, BBNX, and AVNS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025EMBCEmbectaquarterly$0.154.51%5/28/20255/28/20256/13/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.571.56BBNXBeta BionicsN/A15.8814.93EMBCEmbectaN/A2.481.83KRMDKORU Medical Systems0.012.442.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%BBNXBeta BionicsN/AEMBCEmbecta93.83%KRMDKORU Medical Systems58.60%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%BBNXBeta BionicsN/AEMBCEmbecta0.42%KRMDKORU Medical Systems20.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,22746.24 million45.02 millionOptionableBBNXBeta Bionics29443.36 millionN/AN/AEMBCEmbecta2,10058.44 million58.20 millionOptionableKRMDKORU Medical Systems8046.14 million36.64 millionOptionableKRMD, EMBC, BBNX, and AVNS HeadlinesRecent News About These CompaniesKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer - MorningstarJuly 9, 2025 | morningstar.comMKORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial OfficerJuly 7, 2025 | businesswire.comAlbion Financial Group UT Decreases Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)June 30, 2025 | marketbeat.comKRMD KORU Medical Systems, Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comKORU Medical Systems to join Russell 3000 and 2000 indexesJune 11, 2025 | msn.comKORU Medical Systems to Join Russell 3000® and Russell 2000® IndexesJune 11, 2025 | businesswire.comKORU Medical Systems holds annual shareholder meetingMay 17, 2025 | uk.investing.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comHere's What Analysts Are Forecasting For KORU Medical Systems, Inc. (NASDAQ:KRMD) After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comKORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comKORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue GuidanceMay 7, 2025 | businesswire.comEven after rising 14% this past week, KORU Medical Systems (NASDAQ:KRMD) shareholders are still down 75% over the past five yearsMay 1, 2025 | uk.finance.yahoo.comWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 5.80%April 23, 2025 | aaii.comAWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Up 7.49%April 21, 2025 | aaii.comAWhy KORU Medical Systems, Inc.’s (KRMD) Stock Is Down 9.22%April 10, 2025 | aaii.comAKoru Medical management to meet with Craig-HallumApril 9, 2025 | markets.businessinsider.comKORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutionsMarch 20, 2025 | finance.yahoo.comKORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comKORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comKoru Medical reports Q4 EPS (13c), consensus (2c)March 12, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKRMD, EMBC, BBNX, and AVNS Company DescriptionsAvanos Medical NYSE:AVNS$11.53 -0.33 (-2.78%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$11.52 -0.01 (-0.08%) As of 07/15/2025 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Beta Bionics NASDAQ:BBNX$12.53 -0.30 (-2.34%) As of 07/15/2025 04:00 PM EasternBeta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.Embecta NASDAQ:EMBC$9.58 -0.79 (-7.62%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$9.72 +0.14 (+1.47%) As of 07/15/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.KORU Medical Systems NASDAQ:KRMD$2.94 -0.28 (-8.70%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$2.94 0.00 (-0.17%) As of 07/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Fastenal Surges After Earnings Beat, Tariff Risks Loom Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
